GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 …
Oct 9, 2024 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
Statement: Zantac (ranitidine) litigation – settlement agreements ...
Oct 9, 2024 · GSK plc (LSE/NYSE: GSK) today announced that it has reached agreements with 10 plaintiff firms who together represent 93% (approximately 80,000) of the Zantac (ranitidine) state court product liability cases pending against GSK in the United States.
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 …
Oct 9, 2024 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
GSK agrees to pay $2.2B to settle 80K Zantac lawsuits
Oct 9, 2024 · GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British...
GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B - Law.com
Oct 9, 2024 · GlaxoSmithKline has agreed to pay up to $2.2 billion to settle 80,000 Zantac lawsuits. Wednesday's announcement resolves 93% of all Zantac cases in state courts against GSK.
Pharmaceuticals giant GSK to pay $2.2bn to settle Zantac lawsuits
Oct 10, 2024 · UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused...
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement …
Oct 9, 2024 · GSK has agreed to a $2.2 billion settlement to resolve the majority of U.S. state court Zantac lawsuits, with an additional $70 million set aside for a qui tam case. The company maintains...
GSK to pay $2.2B to settle most Zantac lawsuits over claims pill …
Oct 9, 2024 · After protracted legal battling, GSK has agreed to pay up to $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused...
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement …
Oct 9, 2024 · On Wednesday, GSK plc (NYSE: GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for...
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
Oct 10, 2024 · GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with a suspected carcinogen.